<!DOCTYPE article
 PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="preprint"><?all-math-mml yes?><?use-mml?><?origin ukpmcpa?><front><journal-meta><journal-id journal-id-type="nlm-ta">bioRxiv</journal-id><journal-title-group><journal-title>bioRxiv : the preprint server for biology</journal-title></journal-title-group><issn pub-type="epub">2692-8205</issn></journal-meta><article-meta><article-id pub-id-type="manuscript">EMS205911</article-id><article-id pub-id-type="doi">10.1101/2025.05.26.656116</article-id><article-id pub-id-type="archive">PPR1026379</article-id><article-version-alternatives><article-version article-version-type="status">preprint</article-version><article-version article-version-type="number">1</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Mitochondria at synapse utilize fatty acids as a bioenergetic fuel source</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Cetra Antunes</surname><given-names>Bernardo</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Faria-Pereira</surname><given-names>Andreia</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Gonçalves-Ribeiro</surname><given-names>Joana</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Costa-Pinto</surname><given-names>Sara</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Vaz</surname><given-names>Sandra H.</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Morais</surname><given-names>Vanessa A.</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref><xref ref-type="corresp" rid="CR1">*</xref></contrib></contrib-group><aff id="A1"><label>1</label>FMUL Faculdade de Medicina da <institution-wrap><institution-id institution-id-type="ror">https://ror.org/01c27hj86</institution-id><institution>Universidade de Lisboa</institution></institution-wrap>, <city>Lisbon</city>, <country country="PT">Portugal</country></aff><aff id="A2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0346k0491</institution-id><institution>GiMM Gulbenkian Institute for Molecular Medicine</institution></institution-wrap>, <city>Lisbon</city>, <country country="PT">Portugal</country></aff><aff id="A3"><label>3</label>Instituto de Farmacologia e Neurociências, Faculdade de Medicina, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/01c27hj86</institution-id><institution>Universidade de Lisboa</institution></institution-wrap>, <city>Lisbon</city>, <country country="PT">Portugal</country></aff><author-notes><corresp id="CR1">
<label>*</label><bold>Contact Info</bold>, Corresponding Author: Vanessa A. Morais, <email>vmorais@medicina.ulisboa.pt</email>; <email>vanessa.morais@gimm.pt</email></corresp></author-notes><pub-date pub-type="nihms-submitted"><day>28</day><month>05</month><year>2025</year></pub-date><pub-date pub-type="preprint"><day>26</day><month>05</month><year>2025</year></pub-date><permissions><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">CC BY-NC-ND 4.0 International license</ext-link>.</license-p></license></permissions><abstract><title>Summary</title><p id="P1">Mitochondria process glucose, glutamine, and fatty acids (FAs) to produce ATP, with fuel choice dependent on tissue-specific metabolism. The brain harbors two distinct mitochondrial populations—synaptic and non-synaptic. While glucose is the primary fuel for brain bioenergetics, the role of FAs remains elusive. A preliminary proteomic analysis revealed that synaptic mitochondria favor FA metabolism, corroborated by biochemical and respiratory assays showing their higher capacity for β-oxidation and greater respiratory flexibility compared to non-synaptic mitochondria. Additionally, synaptic mitochondria showed higher capacity for FA uptake and less susceptibility to inhibition of the carnitine shuttle system. In neurons, oxygen consumption rate assays indicate that medium to long-chain FA fueling enhances neuronal respiratory flexibility and ATP content, while whole-cell patch-clamp recordings show that long-chain FA fueling sustains increased pre-synaptic activity. Our findings demonstrate that FAs can contribute effectively to synaptic metabolism under normal physiological conditions, where there is a constant demand for energy.</p></abstract><kwd-group><kwd>Synapse</kwd><kwd>Mitochondria</kwd><kwd>Fatty acids</kwd><kwd>Brain Metabolism</kwd></kwd-group></article-meta></front><body><sec id="S1" sec-type="intro"><title>Introduction</title><p id="P2">Synapses host the most energy demanding processes in the brain [<xref ref-type="bibr" rid="R1">1</xref>], and under disease conditions, synaptic damage often precedes neuronal death [<xref ref-type="bibr" rid="R2">2</xref>]. Synapses, often located in considerable distances away from the cell body, in some cases measurable in meters, possess mitochondria with an unique fingerprint to facilitate and secure the homeostasis of synaptic transmission [<xref ref-type="bibr" rid="R1">1</xref>]. Synaptic mitochondria differ from remaining brain mitochondria, often termed non-synaptic, in lipidome and proteome [<xref ref-type="bibr" rid="R3">3</xref>]–[<xref ref-type="bibr" rid="R5">5</xref>], enzymatic expression and activity [<xref ref-type="bibr" rid="R6">6</xref>]–[<xref ref-type="bibr" rid="R8">8</xref>], as well as in shape and size [<xref ref-type="bibr" rid="R1">1</xref>]. Indeed, the fission machinery and smaller size of synaptic mitochondria are crucial for axonal colonization and homeostasis [<xref ref-type="bibr" rid="R9">9</xref>]. Moreover, what these specific differences between sub-compartmentalized mitochondria dictate remains to be clarified.</p><p id="P3">One claim, that is withstanding, is the fact that maintenance of neuronal homeostasis entails a constant energetic supply to support neurotransmission, axonal and dendritic transport, synthesis of neurotransmitters, and protein synthesis, being the dependency on glucose well documented [<xref ref-type="bibr" rid="R10">10</xref>]. However, if glucose alone is enough to keep neuronal circuitry functioning properly, or if additional fuel resources are required remains to be clarified. Fuels such as glutamate [<xref ref-type="bibr" rid="R11">11</xref>] and fatty acids [<xref ref-type="bibr" rid="R12">12</xref>] have been shown to sustain neuronal metabolism to a certain extent. The relevance of fatty acid oxidation (FAO) in the brain has been undermined due to decreased enzymatic efficiency of FAO enzymes in brain mitochondria when compared to mitochondria from other tissues [<xref ref-type="bibr" rid="R10">10</xref>], [<xref ref-type="bibr" rid="R13">13</xref>]. On the other hand, metabolism of fatty acids induced metabolic coupling between neurons and astrocytes [<xref ref-type="bibr" rid="R12">12</xref>], [<xref ref-type="bibr" rid="R14">14</xref>]. With an energetic output that surpasses glucose on more than 2-fold [<xref ref-type="bibr" rid="R10">10</xref>], FAO may be important for neurons, even if only in extreme conditions.</p><p id="P4">The question remains whether glucose alone is sufficient for synaptic mitochondria to cope with the stressful and energy-demanding conditions characteristic of the neuronal periphery, or if additional fuel sources, such as fatty acids, are necessary to maintain synaptic homeostasis.</p><p id="P5">To understand the importance of FAO in neurons, particularly at the synapse, we assessed firstly the metabolic capacity of synaptic mitochondria towards this fuel, in comparison to non-synaptic mitochondria, via enzymatic, oxygen consumption and substrate usability assays, and secondly the effect of FAO in the biology of mouse primary neurons, from respiration to electrical activity. Our data reveals that synaptic mitochondria have a higher propensity for FAO when compared with non-synaptic mitochondria, demonstrating increased enzymatic efficiency, metabolism, uptake capacity, and respiratory output upon stimulation of the electron transport chain. At the cellular level, fueling with fatty acids enhanced neuronal respiration and overall ATP levels, ultimately sustaining increased presynaptic activity, as evidenced by increase spontaneous postsynaptic currents (sPSCs).</p></sec><sec id="S2" sec-type="results"><title>Results</title><sec id="S3"><title>The proteome of synaptic mitochondria shows upregulation of proteins involved in the FAO</title><p id="P6">A proteomic screen previously performed in the host laboratory comparing synaptic and non-synaptic mitochondria isolated from C57BL/6 mice (<xref ref-type="supplementary-material" rid="SD1">Supplementary Fig.1</xref>) (also described in [<xref ref-type="bibr" rid="R15">15</xref>]) revealed increased levels of FAO proteins in synaptic mitochondria (<xref ref-type="fig" rid="F1">Fig. 1A and B</xref>). These proteins are involved both in the carnitine shuttle that imports long-chain fatty acids to mitochondria (carnitine-palmitoyl transferase 2 - CPT2), as well as in the four steps of β-oxidation (acyl-CoA dehydrogenase family member 9 - Acad9, enoyl-CoA hydratase, short chain 1 -Echs1, 3-hydroxyacyl-CoA dehydrogenase type-2- Hsd17b10, and 3-ketoacyl-CoA thiolase - Acaa2), where fatty acids are processed to acetyl-CoA, substrate for the TCA cycle [<xref ref-type="bibr" rid="R16">16</xref>], [<xref ref-type="bibr" rid="R17">17</xref>]. Such a proteome reflects a probable competence of synaptic mitochondria for fatty acid degradation.</p></sec><sec id="S4"><title>Synaptic mitochondria present higher enzymatic efficiency and higher metabolism of fatty acids when compared to non-synaptic mitochondria</title><p id="P7">Enzymatic efficiency for FAO via acyl-CoA dehydrogenase (ACAD) activity in synaptic and non-synaptic mitochondria (described in [<xref ref-type="bibr" rid="R18">18</xref>], [<xref ref-type="bibr" rid="R19">19</xref>]) feed with fatty acids of different chain lengths, revealed a higher ACAD activity in synaptic mitochondria when fueled with long-chain fatty acids (palmitoyl-CoA) (<xref ref-type="fig" rid="F1">Fig.1C</xref>). Complementary immunoblot analysis also showed significantly higher protein levels of acyl-CoA dehydrogenase (LCAD), a protein involved in the processing of long-chain fatty acids in synaptic mitochondria [<xref ref-type="bibr" rid="R20">20</xref>] (<xref ref-type="fig" rid="F1">Fig.1D and E</xref>). When furnished with medium-(octanoyl-CoA) and short-chain (butyryl-CoA) fatty acids, no significant differences were observed at the level of ACAD activity (<xref ref-type="fig" rid="F1">Fig.1C</xref>). To further assess the enzymatic efficiency for FAO, we measured the activity of short-chain 3-hydroxyacyl-CoA dehydrogenase (SCHAD, described in [<xref ref-type="bibr" rid="R21">21</xref>]), often used to assess fatty acid oxidation capacity as it shows broad activity with 3-hydroxyacyl-CoAs ranging from C4 to C16 [<xref ref-type="bibr" rid="R21">21</xref>]. Results obtained reveal a significant increase in SCHAD activity for synaptic mitochondria when compared to their non-synaptic counterparts (<xref ref-type="fig" rid="F1">Fig.1F</xref>). The substrate usability assay using MitoPlates S-1™ measures the ability of mitochondria to metabolize a wide array of substrates, including long-, medium- and short-chain fatty acids. In accordance with the enzymatic assays, we observed significantly higher utilization of long-chain fatty acids by synaptic mitochondria for oxidative metabolism (<xref ref-type="fig" rid="F1">Fig. 1G</xref>).</p><p id="P8">These results indicate that synaptic mitochondria have a more robust enzymatic system for performing fatty acid oxidation (FAO), resulting in a higher metabolic preference for this energy source compared to non-synaptic mitochondria, especially for long-chain fatty acids.</p></sec><sec id="S5"><title>Synaptic mitochondria are more resistant to FAO inhibition</title><p id="P9">Mitochondrial fission is essential for axonal colonization and maintenance of synaptic homeostasis [<xref ref-type="bibr" rid="R9">9</xref>]. Notably, synaptic mitochondria are also known to be smaller compared to overall neuronal mitochondria [<xref ref-type="bibr" rid="R1">1</xref>]. Additionally, different mitochondrial dynamics and morphologies have been associated with different FAO capacities, as mitochondria that undergo fission show reduced malonyl-CoA inhibition of CPT1 [<xref ref-type="bibr" rid="R22">22</xref>]. The crosstalk between FAO and mitochondrial dynamics prompted us to examine the activity of CPT1 in the presence of its allosteric inhibitor malonyl-CoA in synaptic and non-synaptic mitochondria. Data obtained showed that non-synaptic mitochondria suffer a significant inhibition of CPT1 activity in the presence of 40µM malonyl-CoA, while synaptic mitochondria showed higher CPT1 activity in the same conditions (<xref ref-type="fig" rid="F1">Fig.1H</xref>). Interestingly, when evaluating the capacity for fatty acid uptake, synaptic mitochondria were also significantly more competent (<xref ref-type="fig" rid="F1">Fig.1I</xref>).</p><p id="P10">Data obtained in this section shows that synaptic mitochondria have a higher capacity for fatty acid uptake and are simultaneously less sensitive to malonyl-CoA inhibition, which is often associated with smaller, more fissed mitochondria[<xref ref-type="bibr" rid="R22">22</xref>].</p></sec><sec id="S6"><title>FAO increases the respiratory flexibility of brain mitochondria</title><p id="P11">To interrogate the importance of fatty acid fueling in mitochondrial respiratory flexibility, we performed respiratory measurement assays on synaptic and non-synaptic mitochondria using the Seahorse XFe24 Analyzer, fueling mitochondria with long- (palmitoyl-CoA), medium-(octanoyl-CoA) and short-chain (butyril-CoA) fatty acids (<xref ref-type="fig" rid="F2">Fig.2A-C</xref>) in the presence of relevant mitochondrial substrates pyruvate, succinate and malate. A significant increase in coupling of respiratory complexes (response to ADP, ATP production) and respiratory plasticity (spare capacity, maximum respiration) was observed in both mitochondria populations in the presence of long- and medium-chain fatty acids, with benefits to a higher degree observed in synaptic mitochondria for medium-chain fatty acids (<xref ref-type="fig" rid="F2">Fig.2D</xref>). Concerning short-chain fatty acids, results obtained were not as striking, with synaptic mitochondria showing a significant profit only for ATP production (<xref ref-type="fig" rid="F2">Fig.2D</xref>). Non-synaptic mitochondria showed significant inhibition of basal and maximum respirations as well as in their response to ADP when incubated with short-chain fatty acids (<xref ref-type="fig" rid="F2">Fig. 2D</xref>). These experiments demonstrate that neuronal mitochondria benefit from the respiratory flexibility provided by metabolizing longer-chain fatty acids, even when other standard substrates like pyruvate are available.</p></sec><sec id="S7"><title>Long and medium-chain fatty acid metabolism increases the basal respiration of mouse primary neurons</title><p id="P12">To explore how fatty acids may affect mitochondrial function in a cellular context, we assessed mitochondrial respiration in whole primary neurons at 10 days in vitro (DIV10) using the Seahorse XFe24 Analyzer. As long- and medium-chain fatty acids were the substrates with most respiratory benefits in brain mitochondria (<xref ref-type="fig" rid="F2">Fig. 2</xref>), we focus our analysis on those two substrates. We observed that in the presence of glucose, treating cells with 25µM of palmitate or octanoate for 4h, as long- and medium-chain fatty acids respectively, significantly increased neuronal basal respiration (<xref ref-type="fig" rid="F3">Fig.3A,B and C,D</xref>, respectively). Interestingly, pre-incubation with the long-chain FAO inhibitor etomoxir before palmitate treatment was enough to return neuronal basal respiration levels to those of the control (<xref ref-type="fig" rid="F3">Fig.3B</xref>). When cells were treated with etomoxir alone, there was a noticeable but not significant reduction in neuronal basal respiration (<xref ref-type="fig" rid="F3">Fig.3B</xref>). The increase in neurons’ basal respiration mediated by octanoate was accompanied by a decrease in spare capacity and maximum respiration (<xref ref-type="fig" rid="F3">Fig.3D</xref>), suggesting the neuronal respiratory fitness better profits from long-chain fatty acid fueling. Importantly, proton leak values associated with possible risk of mitochondrial damage were not increased by either of the fatty acids in question (<xref ref-type="supplementary-material" rid="SD1">Supplementary Fig.2A and B</xref>). This data shows that both long- and medium-chain fatty acids can benefit neuronal respiration when provided in lower concentrations, particularly for palmitate. Interestingly, inhibiting long-chain FAO was sufficient to deny these effects, showing that long-chain fatty acids can boost the flexibility of neuronal respiration even in the presence of glucose.</p></sec><sec id="S8"><title>Fatty acid fueling significantly contributes to neuronal ATP levels</title><p id="P13">Following the results from the respiratory assays described in the previous section, we aimed to understand the effect of long- and medium-chain fatty acid oxidation on neuronal ATP levels. Mouse primary neurons (DIV10) were treated with palmitate and octanoate for 4h in the presence of glucose and ATP levels were quantified. Fueling primary neurons with palmitate did not affect overall neuronal ATP levels, however when cells were pre-incubated with etomoxir, a significant reduction was observed (<xref ref-type="fig" rid="F4">Fig.4A</xref>). For octanoate oxidation, we also observed a significant increase in primary neuron ATP levels upon medium-chain fatty acid fueling (<xref ref-type="fig" rid="F4">Fig.4B</xref>). Data obtained shows that even in the presence of glucose, preventing long-chain FAO is detrimental to the maintenance of ATP levels in neurons, suggesting a role for FAO in the energetic homeostasis of these cells. At the same time, medium-chain FAO can significantly contribute to the increase in the pool of energy available to neurons.</p></sec><sec id="S9"><title>Neurons naturally uptake fatty acids at the periphery in the presence of glucose</title><p id="P14">As the role of glucose is well known to maintain neuronal homeostasis, evidence starts to arise showing that in the absence of this fuel, fatty acids derived from lipid droplets can sustain electrical activity at neuronal periphery [<xref ref-type="bibr" rid="R23">23</xref>]. Nevertheless, to our knowledge, nobody has yet shown if fatty acid uptake occurs specifically at the synapse in the presence of glucose. To answer this, we cultured mouse primary neurons in microfluidic devices [<xref ref-type="bibr" rid="R24">24</xref>], allowing isolation of axons from the somal region [<xref ref-type="bibr" rid="R15">15</xref>]. In this setup, and after 10 days <italic>in vitro</italic> (DIV10), a 24h pulse of BODIPY 558/568 (Red-C12) was delivered the axonal compartment, and its uptake was assessed at both neuronal (Tubulin β3) and mitochondrial levels (HSP60). Indeed, we observed the uptake of Red-C12 labeled fatty acids uptake at neuronal periphery (<xref ref-type="fig" rid="F5">Fig.5A</xref>). Moreover, some Red-C12 fatty acids were also found near axonal mitochondria, suggesting that even in the presence of glucose fatty acids serve as fuels for axonal mitochondria (<xref ref-type="fig" rid="F5">Fig.5B</xref>). Importantly, exclusive peripheric uptake of fatty acids was confirmed by the absence of signal in the somal compartment (<xref ref-type="supplementary-material" rid="SD1">Supplementary Fig.3A</xref>). Fuel uptake at a whole cellular level was also observed when Red-C12 was delivered to neurons plated in coverslips (<xref ref-type="supplementary-material" rid="SD1">Supplementary Fig.3B</xref>).</p></sec><sec id="S10"><title>Primary neurons show increased pre-synaptic activity upon palmitate fueling</title><p id="P15">Mitochondrial ATP supply at the synapse is well documented and is essential for the maintenance of proper firing activity [<xref ref-type="bibr" rid="R25">25</xref>], [<xref ref-type="bibr" rid="R26">26</xref>]. Although the contribution of glucose has been well documented in this extent [<xref ref-type="bibr" rid="R25">25</xref>], [<xref ref-type="bibr" rid="R27">27</xref>], the question remains if neuronal activity may also benefit from additional fuels such as fatty acids. To assess this, we performed whole-cell patch-clamp recordings in primary neurons (DIV 19-21) treated with 25µM of palmitate or its vehicle control BSA for 4h in complete medium containing glucose (<xref ref-type="fig" rid="F6">Fig.6A</xref>). Spontaneous postsynaptic currents were evaluated, since changes in amplitude reflect postsynaptic alterations, while changes in frequency indicate modifications in presynaptic function or synapse number. Results obtained revealed a significant impact of palmitate in neuronal activity, showing increased current frequency when compared with neurons treated with BSA (<xref ref-type="fig" rid="F6">Fig.6B</xref>). Moreover, incubating primary neurons with etomoxir prior to adding palmitate was sufficient to reduce the frequency of spontaneous postsynaptic currents to control values, thereby confirming the specificity of the effect of long-chain fatty acid oxidation in synaptic activity (<xref ref-type="fig" rid="F6">Fig.6B</xref>). No differences in current amplitude were observed in any of the treatments performed (<xref ref-type="fig" rid="F6">Fig.6C</xref>), as well as in the expression of glutamate receptors, such as NMDAR2A/B and GluA1 (<xref ref-type="fig" rid="F6">Fig.6D and E</xref>). This data suggests that neurons have the flexibility to utilize different fuel sources even in the presence of glucose. The ability to oxidize energy-rich fuels like palmitate may be particularly important in synapses, where there is a constant high demand for energy.</p></sec></sec><sec id="S11" sec-type="discussion"><title>Discussion</title><p id="P16">The long-held dogma that the brain does not rely on FAO is undergoing increasing scrutiny, with research showing that this fuel source can contribute to total brain oxidative energy production [<xref ref-type="bibr" rid="R28">28</xref>], astrocytic metabolism [<xref ref-type="bibr" rid="R29">29</xref>] and metabolic coupling between neurons and glia [<xref ref-type="bibr" rid="R14">14</xref>], [<xref ref-type="bibr" rid="R30">30</xref>]. Recent evidence shows that, in the absence of glucose, fatty acids can be stored in lipid droplets in axons, and its flux to mitochondria for constant degradation is mediated by the DDHD2 lipase, which is why historically it has been assumed that the presence of lipid droplets in neurons is neglectable [<xref ref-type="bibr" rid="R23">23</xref>]. Indeed, DDHD2 loss of function caused lipid droplet accumulation in axons, leading to significant cognitive impairment in humans and mice, advocating the importance of functional metabolism of fatty acids to preserve neuronal health [<xref ref-type="bibr" rid="R23">23</xref>], [<xref ref-type="bibr" rid="R31">31</xref>], [<xref ref-type="bibr" rid="R32">32</xref>]. Nevertheless, evidence for the usage of fatty acids in neuronal and synaptic homeostasis under conditions where glucose is still present remains to be assessed.</p><p id="P17">In this extent, our results provide solid proof that in the presence of glucose, FAO significantly contributes to neuronal homeostasis. We have shown for the first time that fueling neurons with concentrations of palmitate that do not cause lipotoxicity significantly benefits excitatory synaptic activity even in the presence of glucose, which was rescued to basal levels by inhibiting the carnitine shuttle import of palmitate with etomoxir. We observe the same outcome in oxygen consumption assays, whereby fueling neurons with palmitate significantly benefited cellular respiration, while pre-incubation with etomoxir reversed this phenotype. This demonstrates that long-chain fatty acid oxidation (LCFAO) can fuel synaptic activity even in the presence of glucose, challenging the view that glucose is the sole metabolic substrate contributing to maintain homeostasis at neuronal periphery. The fact that we were able to observe the uptake of Red-C12 fatty acids at neuronal periphery in the presence of glucose, and its location in the vicinity of axonal mitochondria, also adds to the view that FAO is a physiologically relevant process at the synapse. Interestingly, neurons incubated with etomoxir experienced a significant decrease in ATP levels, showing their need to resort to FAO even in the presence of glucose to maintain their energy balance. This goes in line with the research from Panov and colleagues that showed that combining fatty acids with either pyruvate, glutamate or succinate increased rates of brain mitochondrial respiration in all metabolic states [<xref ref-type="bibr" rid="R12">12</xref>].</p><p id="P18">The increase in pre-synaptic activity and overall respiratory benefits upon palmitate fueling observed may be linked with an increased specialization of synaptic mitochondria in dealing with this fuel. Our data showed synaptic mitochondria’s flexibility towards FAO is reflected in higher competence in oxidizing fatty acid of longer chain-lengths, with increased activity of β-oxidation enzymes, higher metabolism and capacity for uptake, and less proneness for inhibition via Malonyl-CoA when compared with non-synaptic mitochondria. Moreover, long- to medium-chain fatty acid fueling significantly increased the flexibility of mitochondrial electron transport chain even in the presence of other fuels such as pyruvate. To our knowledge, no studies have evaluated the fuel preference of synaptic mitochondria; however, specific features such as their smaller size and fission dynamics may indicate higher capacity for FAO. A study in HepG2 cells and primary rat hepatocytes from Ngo and colleagues showed a strong correlation between mitochondrial fragmentation and increased FAO rates, as inducing fragmentation led to reduced malonyl-CoA inhibition of CPT1, specifically increasing long-chain FAO [<xref ref-type="bibr" rid="R22">22</xref>]. Our data corroborated this view, as we showed that synaptic mitochondria are more resistant to malonyl-CoA inhibition than non-synaptic mitochondria, which implies that the flow of importing long-chain fatty acids is less prone to disruption. The preference of synaptic mitochondria for degrading fatty acids of higher chain-lengths was strengthened by our enzymatic and substrate usability data, revealing increased enzymatic activity and metabolism in the presence of this fuel. Although the importance of glucose in neuronal and synaptic function is well established [<xref ref-type="bibr" rid="R33">33</xref>], the energetic demands and pressures of the environment surrounding synaptic terminals raises the question of whether additional fuel sources might be beneficial for maintaining proper synaptic circuitry function. Astrocytes, for instance, have shown remarkable flexibility in substrate utilization, demonstrating competence in both glycolysis and fatty acid oxidation (FAO) [<xref ref-type="bibr" rid="R14">14</xref>], [<xref ref-type="bibr" rid="R34">34</xref>]. While they can remove peroxidized lipids that could potentially damage neurons, they also provide lactate to fuel synaptic plasticity [<xref ref-type="bibr" rid="R35">35</xref>], [<xref ref-type="bibr" rid="R36">36</xref>]. Advances in the understanding of astrocyte metabolism have shown also that medium-chain fatty acid (MCFA) fueling promotes astrocytic ketogenesis [<xref ref-type="bibr" rid="R37">37</xref>], suggesting that astrocytes could potentially supply additional fuels, such as ketone bodies or even fatty acids, to the synapse. Altogether, our work shows that the fueling preferences of synaptic mitochondria allow them to deal with energy-rich substrates like fatty acids, which in combination with glucose serve as hubs to sustain neuronal and synaptic homeostasis. Considering that synaptic dysfunction typically precedes neuronal loss, and that metabolic dysfunctions are a key factor in the etiology of brain diseases such as Alzheimer’s (AD), Parkinson’s (PD), and amyotrophic lateral sclerosis (ALS) [<xref ref-type="bibr" rid="R38">38</xref>], [<xref ref-type="bibr" rid="R39">39</xref>], dissecting the metabolic fingerprint of synaptic terminals could be crucial for understanding which pathways become disrupted in neurodegeneration.</p></sec><sec id="S12" sec-type="conclusions"><title>Conclusion</title><p id="P19">Our work unravels for the first time the fuel preference and flexibility of synaptic mitochondria. Synaptic mitochondria play a crucial role in supplying neurons with ATP to maintain proper protein synthesis and synaptic vesicle cycling, as well as a healthy neuronal circuitry [<xref ref-type="bibr" rid="R25">25</xref>], [<xref ref-type="bibr" rid="R40">40</xref>]. Further unravelling synaptic fuel preferences, particularly in a firing state, will be key to understand the early stages of neurodegenerative diseases and ultimately prevent its progression.</p></sec><sec id="S13" sec-type="web-only"><title>STAR★Methods</title><p id="P20">Key resources table</p><table-wrap id="T1" orientation="portrait" position="anchor"><table frame="box" rules="groups"><thead><tr><th valign="top" align="left" style="border-top:solid 2px #000000;border-left:solid 1px #000000">REAGENT or RESOURCE</th><th valign="top" align="left" style="border-top:solid 2px #000000;border-left:solid 1px #000000">SOURCE</th><th valign="top" align="left" style="border-top: 2px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">IDENTIFIER</th></tr></thead><tbody><tr><td valign="top" align="left" colspan="3" style="border-top: 2px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000"><bold>Antibodies</bold></td></tr><tr><td valign="top" align="left" style="border-top:solid 2px #000000;border-left:solid 1px #000000">Anti-LCAD</td><td valign="top" align="left" style="border-top:solid 2px #000000;border-left:solid 1px #000000">Proteintech</td><td valign="top" align="left" style="border-top: 2px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">17526-1-AP; AB_2219661</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Anti-VDAC1</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Abcam</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">ab154856; RRID: AB_2687466</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Anti-NMDAR2A</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Abcam</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">ab169873</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Anti-NMDAR2B</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Abcam</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">ab65783</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Anti-GLUA1</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Millipore</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">AB1504; AB_2113602</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Anti-β-Actin</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Sigma-Aldrich</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">A5441</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Anti-HSP60</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">BD Biosciences</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">611563; RRID: AB_399009</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Anti-β3 tubulin</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">BioLegend</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">802001; RRID: AB_2564645</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Alexa Fluor 488 Anti-Rabbit</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Invitrogen</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">A21206; RRID: AB_2535792</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Alexa Fluor 488 Anti-Mouse</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Invitrogen</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">A21202; AB_141607</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">HRP Conjugated Anti-Mouse</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Bio-Rad</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">1706516; RRID: AB_2921252</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">HRP Conjugated Anti-Rabbit</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Bio-Rad</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">1706515; RRID: AB_11125142</td></tr><tr><td valign="top" align="left" colspan="3" style="border-top: 2px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000"><bold>Chemicals, peptides, and recombinant proteins</bold></td></tr><tr><td valign="top" align="left" style="border-top:solid 2px #000000;border-left:solid 1px #000000">DAPI</td><td valign="top" align="left" style="border-top:solid 2px #000000;border-left:solid 1px #000000">Sigma-Aldrich</td><td valign="top" align="left" style="border-top: 2px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">D9542</td></tr><tr><td valign="top" align="left" style="border-top: 1px solid #000000;border-left: 1px solid">Paraformaldehyde (PFA)</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Electron Microscopy<break/>Sciences</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid">15710</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Bovine Serum Albumin (BSA)</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Sigma-Aldrich</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">A9647</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Hank’s Balanced Salt Solution (HBSS)</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Gibco</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">14175095</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">HEPES</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Gibco</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">15630056</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Trypsin</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Gibco</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">15090046</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">DNase I</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Sigma-Aldrich</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">DN25</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Horse Serum (HS)</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Gibco</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">2605088</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Minimum Essential Medium (MEM)</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Gibco</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">31095029</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Glucose</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Gibco</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">A2494001</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Penicillin-Streptomycin</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Gibco</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">15140122</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">NeuroBasal medium (NB)</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Gibco</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">21103049</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Poly D-Lysine</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Sigma-Aldrich</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">P7280</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">L-Glutamine</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">ThermoScientific</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">25030024</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">B-27</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Gibco</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">17504044</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">VectaShieldAntifade Mounting Medium</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Vector laboratories</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">H-1000</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Sucrose</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Sigma-Aldrich</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">84100</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">D-Mannitol</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Sigma-Aldrich</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">M4125</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">EGTA</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Sigma-Aldrich</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">E4378</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Percoll</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Sigma-Aldrich</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">GE17-0891-02</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Digitonin</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Sigma-Aldrich</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">D141</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Protease Inhibitor</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">ThermoScientific</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">78443</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Malate</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Sigma-Aldrich</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">M1000</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Succinate</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Sigma-Aldrich</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">S2378</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Sodium Pyruvate</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">ThermoScientific</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">LTID 11360-039</td></tr><tr><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">Potassium Phosphate Dihydrogen (KH2PO4)</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">Sigma-Aldrich</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">P5379</td></tr><tr><td valign="top" align="left" style="border-left:solid 1px #000000">Di-Potassium Phosphate (K2HPO4)</td><td valign="top" align="left" style="border-left:solid 1px #000000">Sigma-Aldrich</td><td valign="top" align="left" style="border-left:solid 1px #000000;border-right:solid 1px #000000">795496</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Potassium Cyanide (KCN)</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">VWR</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">26802.234</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Etomoxir</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Sigma-Aldrich</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">E1905</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Rotenone</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Sigma-Aldrich</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">R8875</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Antimycin A</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Sigma-Aldrich</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">A8674</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">FCCP</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Sigma-Aldrich</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">C2920</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Cytochrome C</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Sigma-Aldrich</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">C7752</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Phenazine methosulfate</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Sigma-Aldrich</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">P9625</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">MOPS</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Sigma-Aldrich</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">M1254</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">DTT (Ditiotreitol)</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Biochemica</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">A1101,0025</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Triton X100</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Sigma-Aldrich</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">T8787</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">NADH</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Sigma-Aldrich</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">N8129</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">N-ethylmaleimide</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Sigma-Aldrich</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">E3876</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Acetoacetyl coenzyme A sodium salt hydrate</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Sigma-Aldrich</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">A1625</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Palmitoyl coenzyme A lithium salt</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Sigma-Aldrich</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">P9716</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Octanoyl coenzyme A lithium salt</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Sigma-Aldrich</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">O6877</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Butyryl coenzyme A lithium salt hydrate</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Sigma-Aldrich</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">B1508</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">DTNB (5 5’-Dithiobis(2-Nitrobenzoic Acid)</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Sigma-Aldrich</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">D8130</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">EDTA</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Sigma-Aldrich</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">E5134</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Malonyl coenzyme A</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Sigma-Aldrich</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">M4263</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Carnitine Hydrochloride</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Sigma-Aldrich</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">C0283</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">BODIPY™ 558/568 C12</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Invitrogen</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">D3835</td></tr><tr><td valign="top" align="left" colspan="3" style="border-top: 2px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000"><bold>Critical commercial assays</bold></td></tr><tr><td valign="top" align="left" style="border-top:solid 2px #000000;border-left:solid 1px #000000">Fatty Acid Uptake Probe</td><td valign="top" align="left" style="border-top:solid 2px #000000;border-left:solid 1px #000000">Dojindo</td><td valign="top" align="left" style="border-top: 2px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">UP07</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">ECL Western Blotting reagents</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Cytiva</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">RPN2106</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Pierce™ BCA protein assay kit</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">ThermoScientific</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">23225</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Bio-Rad protein assay</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Bio-Rad</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">5000001</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Seahorse XF Palmitate-BSA FAO Substrate</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Agilent Technologies</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">HPA102720100</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Luminescent ATP Detection Assay Kit</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Abcam</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">ab113849</td></tr><tr><td valign="top" align="left" colspan="3" style="border-top: 2px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000"><bold>Deposited data</bold></td></tr><tr><td valign="top" align="left" style="border-top:solid 2px #000000;border-left:solid 1px #000000">Proteomics Data</td><td valign="top" align="left" style="border-top:solid 2px #000000;border-left:solid 1px #000000">MassIVE</td><td valign="top" align="left" style="border-top: 2px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">MSV000092568</td></tr><tr><td valign="top" align="left" colspan="3" style="border-top: 2px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000"><bold>Experimental models: Organisms/strains</bold></td></tr><tr><td valign="top" align="left" style="border-top:solid 2px #000000;border-left:solid 1px #000000">Mouse: C57BL/6J</td><td valign="top" align="left" style="border-top:solid 2px #000000;border-left:solid 1px #000000">Mice bred in-house</td><td valign="top" align="left" style="border-top: 2px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">N/A</td></tr><tr><td valign="top" align="left" colspan="3" style="border-top: 2px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000"><bold>Software and algorithms</bold></td></tr><tr><td valign="top" align="left" style="border-top:solid 2px #000000;border-left:solid 1px #000000">Prism v8.4.3</td><td valign="top" align="left" style="border-top:solid 2px #000000;border-left:solid 1px #000000">Graphpad</td><td valign="top" align="left" style="border-top: 2px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000"><ext-link ext-link-type="uri" xlink:href="https://www.graphpad.com/">https://www.graphpad.com/</ext-link></td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Fiji (Image J)</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-left: 1px solid"/><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000"><ext-link ext-link-type="uri" xlink:href="https://imagej.net/software/fiji/">https://imagej.net/software/fiji/</ext-link></td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Adobe Illustrator</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-left: 1px solid"/><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000"><ext-link ext-link-type="uri" xlink:href="https://www.adobe.com/">https://www.adobe.com/</ext-link></td></tr><tr><td valign="top" align="left" colspan="3" style="border-top: 2px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000"><bold>Other</bold></td></tr><tr><td valign="top" align="left" style="border-top:solid 2px #000000;border-left:solid 1px #000000">MitoPlates S-1</td><td valign="top" align="left" style="border-top:solid 2px #000000;border-left:solid 1px #000000">Biolog</td><td valign="top" align="left" style="border-top: 2px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">14105</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Microfluidics 450 mm microgroove barrier</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Xona</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">SND450</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Zeiss LSM 880 Confocal microscope</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Zeiss</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">N/A</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Amersham 680 RGB</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">GE Healthcare</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">N/A</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Amersham ImageQuant 800</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">GE Healthcare</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">N/A</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Mini Gel Tank and Blot Module Set</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Invitrogen</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">NW2000</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Potter Elvehjem 30mL</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">Fisher Scientific</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">10669922</td></tr><tr><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">BioTek Synergy HTX Multimode Reader</td><td valign="top" align="left" style="border-top:solid 1px #000000;border-left:solid 1px #000000">BioSPX</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid"/></tr><tr><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">Seahorse XF24e Analyzer</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">Agilent Technologies</td><td valign="top" align="left" style="border-top: 1px solid #000000;border-bottom: 1px solid #000000;border-right: 1px solid #000000;border-left: 1px solid #000000">S7801B</td></tr></tbody></table></table-wrap></sec><sec id="S14"><title>Experimental model and study participant details</title><sec id="S15"><title>Animals</title><p id="P21">C57BL/6J mice were obtained and housed in the Rodent Facility from Gulbenkian Institute for Molecular Medicine (GIMM), in a temperature-controlled room at 20-24°C. Stud males were housed individually. Females were housed in groups of 2-5 per cage and synchronization of their estrous cycles was achieved by exposing them to male’s urine 48h prior to mating. Whole brains from embryos at embryonic day 18 (E18) were used for the establishment of primary neuron cultures. All the procedures were approved by the Portuguese National Authority for Animal Health (DGAV), as well as by the institute’s animals’ well-being office (ORBEA-iMM). The study was carried out in compliance with the ARRIVE guidelines [<xref ref-type="bibr" rid="R15">15</xref>].</p></sec></sec><sec id="S16"><title>Methods details</title><sec id="S17"><title>Isolation of synaptic and non-synaptic mitochondria from mouse brain</title><p id="P22">Brains were isolated from 8 weeks old C57BL/6J female mice and synaptic and non-synaptic mitochondrial enriched fraction was performed as previously described [<xref ref-type="bibr" rid="R16">16</xref>]. Briefly, tissue homogenization was performed in cold isolation buffer (IB) containing 10mM HEPES, 225mM sucrose, 75mM D-Mannitol and 1mM EGTA, pH 7.4 followed by a centrifugation at 600xg, 10min, 4ºC. Supernatant was then collected and further centrifuged at 15000xg, 10min, 4ºC, resuspended in 15% Percoll and applied on an ascending Percoll gradient of 40% and 24%. Synaptosomes (in the interphase 15% - 24% Percoll) and non-synaptic mitochondria (in the interphase 24% - 40% Percoll) were collected and resuspended in cold IB and centrifuged at 20,000xg and 10,000xg for 10min, 4ºC. To collect synaptic mitochondria, synaptosomes were disrupted with 0,6mg/mL of digitonin for 15min in agitation, 4ºC, followed by two centrifugations at 10,000xg, 10min, 4ºC. The protein content of isolated brain mitochondria fraction samples was measured using Pierce™ BCA Protein Assay Kit. Isolated mitochondrial fractions were used fresh or stored at -80º until further use.</p></sec><sec id="S18"><title>Proteomics</title><p id="P23">The stable 15N isotope labelling of mammals was accomplished essentially as previously described.52,53 Briefly, FVB mice of both sexes were purchased immediately after weaning. After a week-long acclimation, mice were placed on ad libitum 15Ndiet (MF-SpirulinaN-IR; Cambridge Isotopes). For the dynamic labelling experiments (single-generation), mice stayed on the 15N diet for 4 months and were sacrificed. Mice were anesthetized with 3% isoflurane followed by acute decapitation. Brain tissues were harvested, flash frozen in a dry ice/ethanol bath, and stored at -80ºC. For consequent MS studies, brain homogenates from naturally occurring N14 fresh brains from C57BL/6J female mice were mixed in a 1:1 ratio with brain homogenates coming from N15 labelled frozen brains. From the N14/N15 mixed brain homogenate, mitochondria were isolated as described above.</p></sec><sec id="S19"><title>MS sample preparation</title><p id="P24">Mitochondrial samples were homogenized in the lysis buffer (0.1 M Tris-HCl, pH 7.6, 20% SDS and 1 M DTT with 13 protease inhibitor cocktail. 54 The mixtures were incubated at 95ºC for 5 min. The samples were then sonicated for 10 min and centrifuged at 16,100 x g for 10 min. The supernatant was collected and the proteins were precipitated by the methanol/chloroform method. Protein pellets were resuspended in 8M urea prepared in 100 mM ammonium bicarbonate solution and processed with ProteaseMAX according to the manufacturer’s protocol. The samples were reduced with 5 mM Tris(2-carboxyethyl)phosphine (TCEP; vortexed for 1 hour at RT), alkylated in the dark with 10 mM iodoacetamide (IAA; 20 min at RT), diluted with 100 mM ABC, and quenched with 25 mM TCEP. Samples were diluted with 100 mM ammonium bicarbonate solution, and digested with Trypsin (1:50,) for overnight incubation at 37 C with intensive agitation. The next day, reaction was quenched by adding 1% trifluoroacetic acid (TFA). The samples were desalted using Peptide Desalting Spin Columns. All samples were vacuum centrifuged to dry.</p></sec><sec id="S20"><title>Tandem mass spectrometry</title><p id="P25">Three micrograms of each sample were auto-sampler loaded with a Thermo EASY nLC 100 UPLC pump onto a vented Acclaim Pepmap 100, 75 um x 2 cm, nanoViper trap column coupled to a nanoViper analytical column (3 mm, 100 A°, C18, 0.075 mm, 500 mm) with stainless steel emitter tip assembled on the Nanospray Flex Ion Source with a spray voltage of 2000 V. An Orbitrap Fusion was used to acquire all the MS spectral data. Buffer A contained 94.785% H2O with 5% ACN and 0.125% FA, and buffer B contained 99.875% ACN with 0.125% FA. The chromatographic run was for 4 hours in total with the following profile: 0-7% for 7, 10% for 6, 25% for 160, 33% for 40, 50% for 7, 95% for 5 and again 95% for 15 mins receptively. Samples were injected and analyzed by three or six times. We used CID-MS2 method for these experiments as previously described.55 Briefly, ion transfer tube temp = 300ºC, Easy-IC internal mass calibration, default charge state = 2 and cycle time = 3 s. Detector type set to Orbitrap, with 60K resolution, with wide quad isolation, mass range = normal, scan range = 300-1500 m/z, max injection time = 50 ms, AGC target = 200,000, microscans = 1, S-lens RF level = 60, without source fragmentation, and datatype = positive and centroid. MIPS was set as on, included charge states = 2-6 (reject unassigned). Dynamic exclusion enabled with n = 1 for 30 s and 45 s exclusion duration at 10 ppm for high and low. Precursor selection decision = most intense, top 20, isolation window = 1.6, scan range = auto normal, first mass = 110, collision energy 30%, CID, Detector type = ion trap, OT resolution = 30K, IT scan rate = rapid, max injection time = 75 ms, AGC target = 10,000, Q = 0.25, inject ions for all available parallelizable time.</p></sec><sec id="S21"><title>MS data analysis and quantification</title><p id="P26">Protein identification/quantification and analysis were performed with Integrated Proteomics Pipeline - IP2 (Bruker, Madison, WI. <ext-link ext-link-type="uri" xlink:href="http://www.integratedproteomics.com/">http://www.integratedproteomics.com/</ext-link>) using ProLuCID,56,57 DTASelect2,58,59 Census and Quantitative Analysis. Spectrum raw files were extracted into MS1, MS2 files using RawConverter (<ext-link ext-link-type="uri" xlink:href="http://fields.scripps.edu/downloads.php">http://fields.scripps.edu/downloads.php</ext-link>). The tandem mass spectra (raw files from the same sample were searched together) were searched against UniProt mouse (downloaded on 03-25-2014) protein databases60 and matched to sequences using the ProLuCID/SEQUEST algorithm (ProLuCID version 3.1) with 50 ppm peptide mass tolerance for precursor ions and 600 ppm for fragment ions. The search space included all fully and half-tryptic peptide candidates within the mass tolerance window with no-miscleavage constraint, assembled, and filtered with DTASelect2 through IP2. To estimate protein probabilities and false-discovery rates (FDR) accurately, we used a target/decoy database containing the reversed sequences of all the proteins appended to the target database.60 Each protein identified was required to have a minimum of one peptide of minimal length of six amino acid residues; however, this peptide had to be an excellent match with an FDR &lt; 1% and at least one excellent peptide match. After the peptide/spectrum matches were filtered, we estimated that the protein FDRs were%1% for each sample analysis. Resulting protein lists include subset proteins to allow for consideration of all possible protein forms implicated by at least two given peptides identified from the complex protein mixtures. Then, we used Census and Quantitative Analysis in IP2 for protein quantification. Static modification: 57.02146 C for carbamidomethylation. Quantification was performed by the built-in module in IP2.</p></sec><sec id="S22"><title>Acyl-CoA dehydrogenase assay</title><p id="P27">The activity of Acyl-CoA dehydrogenase was measured in non-synaptic and synaptic mitochondria isolated from 8 weeks old C57BL/6J female mice as described in [<xref ref-type="bibr" rid="R17">17</xref>]. Briefly, 50µg of mitochondrial protein was preincubated in the presence of test compounds for 3min in assay buffer containing 34mM potassium phosphate, 1.5mM KCN, 3.75µM rotenone, 1.5mM cytochrome C, 3mM phenazine methosulfate, pH7.2. The reaction was then started by the addition of 50µM palmitoyl-CoA, 100µM octanoyl-CoA or 200µM butyryl-CoA. Depending on the substrate used, reactions were monitored at 550 nm over a period up to 3h using a spectrophotometer (Synergy HTX Multi-Mode Reader, BioTek).</p></sec><sec id="S23"><title>3-hydroxyacyl-CoA dehydrogenase assay</title><p id="P28">The activity of 3-hydroxyacyl-CoA dehydrogenase was measured in isolated mitochondria from 8 weeks old C57BL/6J female mice [<xref ref-type="bibr" rid="R18">18</xref>]. Assay medium consisted of 0.1M potassium phosphate, 0.5M MOPS, 100µM DTT, 0.1% (w/v) TritonX-100, 150µM NADH, 5mM N-ethylmaleimide, pH6.16. 50µM of acetoacetyl-CoA was provided as substrate to the reaction. A concentration of 50ug of mitochondrial protein was used per well. Reaction was measured at 37°C by following the decrease in absorbance at 340nm using a spectrophotometer (Synergy HTX Multi-Mode Reader, BioTek).</p></sec><sec id="S24"><title>Substrate profiling assay</title><p id="P29">To determine mitochondrial metabolic activity and substrate specificity, MitoPlates S-1 (#14105, Biolog) assays were performed according to the manufacturer’s instructions. Briefly, assay mix was added into all wells of a MitoPlate and the plate was incubated at 37°C for 1h to allow substrates to dissolve. Freshly isolated mitochondria were resuspended in 1×Biolog Mitochondrial Assay Solution (MAS) and dispensed into each well of a MitoPlate (40ug of mitochondrial protein per well). Color formation at 590nm was read kinetically for 2h using a spectrophotometer (Synergy HTX Multi-Mode Reader, BioTek) and the background was corrected for the blank sample. Results are presented as average rate per minute per ug of protein.</p></sec><sec id="S25"><title>CPT1 activity in isolated brain mitochondria</title><p id="P30">CPT1 activity was measured using a colorimetric assay based on the literature [<xref ref-type="bibr" rid="R19">19</xref>]. Briefly, 15μg of mitochondrial protein was loaded onto 96-well plates in 200μl of reaction buffer containing 2mM DTNB, 116mM Tris–HCl [pH 8.0], 2.5mM EDTA, and 0.2% Triton-X 100. CPT1 inhibitor, Malonyl-CoA, or its vehicle control was also added to the reaction buffer at a final concentration of 40µM. The plates were incubated at room temperature for 20min to eliminate all pre-existing reactive thiol groups, and the reaction was initiated by adding 100µM palmitoyl-CoA as a CPT1 substrate and 1mM carnitine as a CPT1 cofactor respectively. After 10min incubation at 37°C, release of CoA-SH from palmitoyl-CoA was spectrophotometrically determined as a readout of CPT1 activity at 412nm using a spectrophotometer (Synergy HTX Multi-Mode Reader, BioTek) in kinetics mode with 20-s intervals for a total assay time of 1h.</p></sec><sec id="S26"><title>Fatty acid uptake in isolated brain mitochondria</title><p id="P31">Fatty acid uptake capacity was measured in isolated brain mitochondria using a Fatty Acid Uptake probe (#UP07 – Dojindo) as per manufacturer’s instructions. Briefly, 8µg of mitochondrial protein was loaded onto a 96 well plate and the plate was centrifuged at 2000xg for 5min to seed mitochondria in the bottom of the wells. The plate was then incubated for 15min at 37°C, after which 0.2µl of the Fatty Acid Uptake probe were added to the wells (in a total volume of 100µl). The plate was incubated for another 15min at 37°C, after which 100µl of Quenching buffer was added per well. Fluorescence was measured (excitation at 485nm; emission at 535nm) using a spectrophotometer (Synergy HTX Multi-Mode Reader, BioTek).</p></sec><sec id="S27"><title>Immunoblot analysis</title><p id="P32">For immunoblot analysis, equal amount of mitochondrial protein extracts (20μg/well) were separated by SDS-PAGE (Invitrogen) in MOPS-SDS running buffer and transferred onto 0.2µm nitrocellulose membranes for 1h at 30V. Membranes were then blocked with 5% milk in TBS-T (20mM Tris-HCl pH7.5, 150mM NaCl, 0.5% Tween-20) for 1h. Primary antibody incubations were performed overnight at 4ºC. Washes were performed for 5min at RT in TBS-T. Incubation with secondary antibodies conjugated with horseradish peroxidase (HRP) were incubated for 2h at RT. Detection was done using the chemiluminescent ECL-Plus detection kit (Amersham) on a digital Amersham Imager 680 or 800 (GE Healthcare).</p></sec><sec id="S28"><title>Mouse primary neuronal cultures</title><p id="P33">Primary neuronal cultures were obtained from whole brain of E18 embryonic C57BL/6 mice, as previously described [<xref ref-type="bibr" rid="R20">20</xref>]. Briefly, brains were collected in Hank’s Balanced Salt Solution supplemented with 1M HEPES (HBSS-HEPES). Meninges were removed and brain tissue was homogenized and dissociated with 0.25% trypsin + 10µl/ml DNaseI in HBSS-HEPES for 15min at 37ºC. Tissue was washed with 10% Horse serum (HS) in HBSS-HEPES and centrifuged 1200xg for 10min at RT. Supernatant was discarded and pellet was washed twice with HBSS-HEPES. Pellet was resuspended in 10% HS in Minimum Essential Medium (MEM) with 0.6% Glucose and 100U/ml Penicillin-Streptomycin (MEM-HS) and strained using a 70µm cell strainer. Cell viability was assessed using Trypan blue. Cells were plated at different densities depending on the assay, on plates coated with 0.01mg/ml Poly-D-Lysine hydrobromide. After 4h, medium was replaced with Neurobasal medium supplemented 0.5mM L-Glutamine, 20U/ml Penicillin-Streptomycin and 2% B-27 (NB-B27).</p></sec><sec id="S29"><title>Mitochondrial respiration measurements</title><p id="P34">Mitochondrial respiration was assessed by measuring the oxygen consumption rate (OCR) using the XFe24 Extracellular Flux Analyzer (Seahorse Bioscience, Agilent, USA). For brain mitochondria, freshly collected synaptic and non-synaptic mitochondrial fraction (8μg of total protein concentration) were resuspended in mitochondrial assay solution (MAS)[<xref ref-type="bibr" rid="R21">21</xref>] and plated in a 24-well Seahorse plate followed by centrifugation 2000 x g, 5min, 4ºC. After centrifugation, 450μl MAS supplemented with 10mM malate, 10mM succinate and 10mM pyruvate, pH 7.4 was added to the plate. Fatty acid substrates 40µM palmitoyl-CoA + L-carnitine, 100µM octanoyl-CoA and 200µM butyryl-CoA were diluted in the supplemented MAS. OCR measurements were performed over 2min after a 30s mix and 10s periods. Three measurements were collected for basal respiration, followed by two measurements after addition of 2mM ADP, followed by two measurements after addition of 20μM Oligomycin, followed by two measurements after addition of 20μM Carbonyl cyanide-4- (trifluoromethoxy) phenylhydrazone (FCCP), followed by two measurements after addition of 20μM Rotenone and 20μM Antimycin A.</p><p id="P35">For primary neuronal cultures, OCR experiments were performed on E18 mouse neurons at 10 days in vitro (DIV), and an Agilent Seahorse XF Palmitate-BSA FAO Substrate protocol was performed with slight modifications. Neurons were placed in FAO assay buffer containing 111mM NaCl, 4.7mM KCL, 1.25Mm CaCl2, 2mM MgSO4 and 1.2mM NaH2PO4, supplemented with 2.5mM Glucose, 0.5mM L-Carnitine and 5mM HEPES, pH=7.4, and incubated for 4h at 37ºC. FAO buffer was also supplemented with long- and medium-chain fatty acids in the form of 25µM palmitate and 25µM octanoate or BSA vehicle control. To assess the effect of inhibiting the metabolism of long-chain fatty acids, neurons were pre-incubated with 10µM etomoxir 15 minutes prior to the addition of fatty acids to the medium.</p><p id="P36">OCR measurements were performed over 3min after a 3min mix and 2min wait periods. Four measurements were collected for basal respiration, followed by three measurements after addition of 1.25μM Oligomycin, three measurements after addition of 0.5μM FCCP, and three measurements after addition of 1μM Antimycin A and 1μM Rotenone.</p></sec><sec id="S30"><title>ATP content in neurons</title><p id="P37">The ATP content was measured in DIV10 neurons treated for 4h with 25µM Palmitate or Octanoate. The effect of 10µM etomoxir was also assessed. ATP content was determined using the Luminescent ATP Detection Assay Kit as per manufacturer’s instructions (Abcam, ab113849). Cells were lysed and collected with 350μl 1x Detergent Mix, mixed for 5 min at 600rpm at RT, and centrifuged at 10000xg for 1min at RT. 150μl of each sample, as well as 10μl of each standard and 140μl of 1x Detergent Mix were pipetted in a flat 96-well plate and incubated with 50μl of Substrate Solution at RT protected from light for 5min with agitation, followed by 10min without agitation. Luminescence of samples, blanks and standard wells were measured using a spectrophotometer (Synergy HTX Multi-Mode Reader, BioTek). From the ATP content standards, a standard curve was plotted and then used to determine the ATP content of each sample. All ATP content levels were normalized to protein levels quantified using the Bradford Protein Quantification Assay.</p></sec><sec id="S31"><title>BODIPY 558/568 C12 uptake in neurons</title><p id="P38">To assess fatty acid uptake, primary neurons were plated at 1x105 cells/well on 13mm coverslips (in a 24 well tissue culture plate). DIV10 neurons were incubated with 2μM BODIPY 558/568 C12 (referred as Red-C12 from here onwards) for 24h in NB-B27 media. Neurons were then transferred to NB-B27 media without Red-C12 for 1h. Neurons were washed and chased for 4 hours in NB-B27 media. To evaluate fatty acid uptake in neuronal periphery, 8x104 cells were plated in microfluidic devices [<xref ref-type="bibr" rid="R22">22</xref>], [<xref ref-type="bibr" rid="R23">23</xref>], 2-compartment devices with 450µm microgroove barrier. Fresh NB-B27 was added every 3 days. A volume difference between the somal (170-180µL) and the axonal (120-130µL) compartments was maintained to create a hydrostatic pressure, thus fluidically isolating each compartment. The Red-C12 incubation procedure described above was applied to neurons, exclusively in the axonal compartment. Neurons were then subjected to an immunofluorescence protocol as described below.</p></sec><sec id="S32"><title>Immunofluorescence assay</title><p id="P39">Neurons (DIV10) were washed in PBS+/+ (0.33mM MgCl2.6H2O, 0.9mM CaCl2.2H2O) and fixed in 4% paraformaldehyde (PFA) in PBS+/+ for 20min at RT. Neurons were permeabilized with 0.5% Triton X-100 in PBS+/+ for 10min at RT and washed with PBS. Blocking was performed for 1h at RT with blocking buffer (0.2% gelatine, 2% FBS, 2% BSA, 0.3% Triton X-100 in PBS) supplemented with 5% goat serum followed by primary antibody incubation overnight at 4ºC. Incubation with secondary antibodies conjugated with Alexa-Fluorophores and DAPI (1µg/mL) was performed for 1h at RT. Coverslips were mounted on Vectashield (#H1000 - Vector Laboratories).</p><p id="P40">For microfluidics, neurons were pre-fixed for 5min at 37ºC with 5% CO2, by adding 4% PFA to each compartment (together with NB-B27). Pre-fixation solution was removed, and 4% PFA was added to each compartment for 20min at RT. Each compartment was washed with PBS+/+. Microfluidic chamber was carefully removed, and coverslip was washed with PBS+/+. Neurons were permeabilized with 0.5% Triton X-100 and immunofluorescence protocol proceeded as mentioned above.</p></sec><sec id="S33"><title>Whole-cell patch-clamp recordings</title><p id="P41">For whole-cell patch-clamp recordings, primary neurons were seed in 13mm coverslips that were mounted in a Carl Zeiss Axioskop 2FS upright microscope (Jena, Germany) equipped with an AxioCam MRm (Zeiss), a 40x immersion objective with 2 and 4 zoom (i.e. up to 160x magnification) and a differential interference contrast-infrared (DIC-IR) CCD video camera (VX44, Till Photonics, Gräfelfing, Germany) [<xref ref-type="bibr" rid="R41">41</xref>]. Whole-cell patch-clamp recordings were performed using electrodes pulled from borosilicate glass capillaries (1.5mm outer diameter, 0.86mm inner diameter, GC150F-10, Harvard Apparatus, Holliston, MA, USA) in a PC-10 vertical (Narishige Group, London, UK) microelectrode puller. The intracellular solution used in this study contained 125mM K-Gluconate, 11mM KCl, 10mM HEPES, 10 mM Phosphocreatine, 2mM MgATP, MgCl2 2mM, 2mM EGTA, 0,3mM NaGTP and 0,1mM CaCl<sub>2,</sub> pH=7.3 (adjusted with KOH 1 M), 280–290 mOsm. Patch-clamp recordings were performed in a submerged recording chamber that was continuously superfused by an open gravitational superfusion system at 2-3 mL/min with artificial cerebrospinal fluid (aCSF – 124mM NaCl, 26mM CaHCO<sub>3</sub>, 10mM Glucose Monohydrate, 10mM Phosphocreatine, 3mM KCl, 2mM CaCl<sub>2</sub>, 1.25mM NaH<sub>2</sub>PO<sub>4,</sub> 1mM MgSO<sub>4</sub>) oxygenated with 95% O<sub>2</sub> and 5% CO<sub>2</sub>, at room temperature. Data was recorded with an Axopatch 200B (Axon Instruments) amplifier. For all patch-clamp recordings, whole-cell access was established following formation of a gigaseal (&gt;1 GΩ) between pipette tip and cell membrane. Immediately after having whole-cell access, the membrane potential of the neurons was measured in current clamp mode (VH approximately = -60 mV). The acquired signals were filtered using a 2 kHz lowpass Bessel filter, and data were digitized at 10 kHz using Digidata 1440A and registered by the Clampex software (version 11.0.3, Molecular Devices).</p><p id="P42">The spontaneous postsynaptic currents were recorded in the voltage-clamp mode for 5 min.</p></sec></sec><sec id="S34"><title>Quantification and statistical analysis</title><p id="P43">For all the quantitative analysis, at least 3 independent experiments from 3 different primary neuronal cultures, or 3 different mitochondrial isolation protocols were performed. The statistical analysis was implemented using Prism 8.4.3 software (GraphPad). An appropriate statistical test was chosen based on the dataset. Detailed information is provided in each figure legend.</p></sec><sec sec-type="supplementary-material" id="SM"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>Supplementary Material</label><media xlink:href="EMS205911-suppement-Supplementary_Material.pdf" mimetype="application" mime-subtype="pdf" id="d14aAcIbB" position="anchor"/></supplementary-material></sec></body><back><ack id="S35"><title>Acknowledgements</title><p>We would like to thank Bart de Strooper and Kathleen Craessaerts (VIB, Leuven, Belgium) for their initial support to this project and for sharing fruitful scientific discussions. We acknowledge also Jeffrey Savas and his team for all the help with performing and analysing the proteomics data. We thank the members of the VMorais Lab for their support and feedback. We would also like to thank the BioImaging Facility and the Rodent Facility of Gulbenkian Institute for Molecular Medicine for their technical support, and we also acknowledge the funding PPBI-POCI-01-3700145-FEDER-022122.</p><sec id="S36"><title>Funding</title><p>This project was supported by European Molecular Biology Organization (EMBO-IG/3309 to V.A.M.); European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (Grant Agreement No. 679168 to V.A.M.); and Fundação para a Ciência e a Tecnologia (FCT) (PTDC/BIA-CEL/31230/2017; PTDC/MED/-NEU/7976/2020 to V.A.M.); Ministério da Ciência, Tecnologia e Ensino Superior (MCTES) through Fundos do Orçamento de Estado (FPJ 1081 Financiamento Estratégico 2019; UID/BIM/50005/2019); the International Society for Neurochemistry (Carer Development Grant 2021 to S.H.V.).</p><p>B.C.A. was holder of a FCT PhD fellowship (2020.05088.BD) and is holder of a fellowship (GIMM/BI/14-2024); A.F.-P. was a holder of fellowships (PD/BD/114113/2015; IMM/BI/76-2019) and V.A.M. was an iFCT researcher (IF/01693/2014; IMM/CT/27-2020; 2021.03613.CEECIND). J. G-R. (PD/BD/150342/2019) and S.C-P. (SFRH/BD/147277/2019 to SC-P) were holders of a FCT PhD fellowships.</p></sec></ack><fn-group><fn fn-type="con" id="FN1"><p id="P44"><bold>Author Contributions</bold></p><p id="P45">Conceptualization: B.C.A. and V.A.M.; methodology: B.C.A., A.F.P., J.G.R., S.C.P., S.H.V.; formal analysis: B.C.A. and V.A.M.; investigation: B.C.A. and V.A.M.; writing – original Draft: B.C.A.; writing – review and editing: B.C.A. A.F.P. and V.A.M.; funding acquisition, V.A.M.; supervision: V.A.M.</p><p id="P46">All authors have read and agreed to the published version of the article.</p></fn><fn fn-type="conflict" id="FN2"><p id="P47"><bold>Declaration of Interests</bold></p><p id="P48">All authors have nothing to declare.</p></fn></fn-group><ref-list><ref id="R1"><label>[1]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fedorovich</surname><given-names>SV</given-names></name><name><surname>Waseem</surname><given-names>TV</given-names></name><name><surname>Puchkova</surname><given-names>LV</given-names></name></person-group><article-title>Biogenetic and morphofunctional heterogeneity of mitochondria: The case of synaptic mitochondria</article-title><source>Rev Neurosci</source><year>2017</year><volume>28</volume><issue>4</issue><fpage>363</fpage><lpage>373</lpage><pub-id pub-id-type="pmid">28195557</pub-id></element-citation></ref><ref id="R2"><label>[2]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soukup</surname><given-names>S</given-names></name><name><surname>Vanhauwaert</surname><given-names>R</given-names></name><name><surname>Verstreken</surname><given-names>P</given-names></name></person-group><article-title>Parkinson’s disease: convergence on synaptic homeostasis</article-title><source>EMBO J</source><year>2018</year><volume>37</volume><issue>18</issue><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type="pmcid">PMC6138432</pub-id><pub-id pub-id-type="pmid">30065071</pub-id><pub-id pub-id-type="doi">10.15252/embj.201898960</pub-id></element-citation></ref><ref id="R3"><label>[3]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiebisch</surname><given-names>Michael A</given-names></name><etal/></person-group><article-title>Lipidomic analysis and electron transport chain activities in C57BL/6J mouse brain mitochondria</article-title><source>J Neurochem</source><year>2008</year><volume>106</volume><issue>1</issue><fpage>299</fpage><lpage>312</lpage><pub-id pub-id-type="pmcid">PMC3104050</pub-id><pub-id pub-id-type="pmid">18373617</pub-id><pub-id pub-id-type="doi">10.1111/j.1471-4159.2008.05383.x</pub-id></element-citation></ref><ref id="R4"><label>[4]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stauch</surname><given-names>KL</given-names></name><name><surname>Purnell</surname><given-names>PR</given-names></name><name><surname>Fox</surname><given-names>HS</given-names></name></person-group><article-title>Quantitative proteomics of synaptic and nonsynaptic mitochondria: Insights for synaptic mitochondrial vulnerability</article-title><source>J Proteome Res</source><year>2014</year><volume>13</volume><issue>5</issue><fpage>2620</fpage><lpage>2636</lpage><pub-id pub-id-type="pmcid">PMC4015687</pub-id><pub-id pub-id-type="pmid">24708184</pub-id><pub-id pub-id-type="doi">10.1021/pr500295n</pub-id></element-citation></ref><ref id="R5"><label>[5]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Völgyi</surname><given-names>K</given-names></name><etal/></person-group><article-title>Synaptic mitochondria: A brain mitochondria cluster with a specific proteome</article-title><source>J Proteomics</source><year>2015</year><volume>120</volume><fpage>142</fpage><lpage>157</lpage><pub-id pub-id-type="pmid">25782751</pub-id></element-citation></ref><ref id="R6"><label>[6]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leong</surname><given-names>SF</given-names></name><name><surname>Lai</surname><given-names>JCK</given-names></name><name><surname>Lim</surname><given-names>L</given-names></name><name><surname>Clark</surname><given-names>JB</given-names></name></person-group><article-title>The Activities of Some Energy-Metabolising Enzymes in Nonsynaptic (Free) and Synaptic Mitochondria Derived from Selected Brain Regions</article-title><source>J Neurochem</source><year>1984</year><volume>42</volume><issue>5</issue><fpage>1306</fpage><lpage>1312</lpage><pub-id pub-id-type="pmid">6707635</pub-id></element-citation></ref><ref id="R7"><label>[7]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dagani</surname><given-names>F</given-names></name><name><surname>Gorini</surname><given-names>A</given-names></name><name><surname>Polgatti</surname><given-names>M</given-names></name><name><surname>Villa</surname><given-names>RF</given-names></name><name><surname>Benzi</surname><given-names>G</given-names></name></person-group><article-title>Rat cortex synaptic and nonsynaptic mitochondria: Enzymatic characterization and pharmacological effects of naftidrofuryl</article-title><source>J Neurosci Res</source><year>1983</year><volume>10</volume><issue>2</issue><fpage>135</fpage><lpage>140</lpage><pub-id pub-id-type="pmid">6313951</pub-id></element-citation></ref><ref id="R8"><label>[8]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKenna</surname><given-names>MC</given-names></name><name><surname>Hopkins</surname><given-names>IB</given-names></name><name><surname>Lindauer</surname><given-names>SL</given-names></name><name><surname>Bamford</surname><given-names>P</given-names></name></person-group><article-title>Aspartate aminotransferase in synaptic and nonsynaptic mitochondria: Differential effect of compounds that influence transient hetero-enzyme complex (metabolon) formation</article-title><source>Neurochem Int</source><year>2006</year><volume>48</volume><issue>6–7</issue><fpage>629</fpage><lpage>636</lpage><pub-id pub-id-type="pmid">16513215</pub-id></element-citation></ref><ref id="R9"><label>[9]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>TL</given-names></name><name><surname>Kwon</surname><given-names>SK</given-names></name><name><surname>Lee</surname><given-names>A</given-names></name><name><surname>Shaw</surname><given-names>R</given-names></name><name><surname>Polleux</surname><given-names>F</given-names></name></person-group><article-title>MFF-dependent mitochondrial fission regulates presynaptic release and axon branching by limiting axonal mitochondria size</article-title><source>Nat Commun</source><year>2018</year><volume>9</volume><issue>1</issue><fpage>1</fpage><lpage>15</lpage><pub-id pub-id-type="pmcid">PMC6258764</pub-id><pub-id pub-id-type="pmid">30479337</pub-id><pub-id pub-id-type="doi">10.1038/s41467-018-07416-2</pub-id></element-citation></ref><ref id="R10"><label>[10]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schönfeld</surname><given-names>P</given-names></name><name><surname>Reiser</surname><given-names>G</given-names></name></person-group><article-title>Brain energy metabolism spurns fatty acids as fuel due to their inherent mitotoxicity and potential capacity to unleash neurodegeneration</article-title><source>Neurochem Int</source><year>2017</year><volume>109</volume><fpage>68</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">28366720</pub-id></element-citation></ref><ref id="R11"><label>[11]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Divakaruni</surname><given-names>AS</given-names></name><etal/></person-group><article-title>Inhibition of the mitochondrial pyruvate carrier protects from excitotoxic neuronal death</article-title><source>J Cell Biol</source><year>2017</year><volume>216</volume><issue>4</issue><fpage>1091</fpage><lpage>1105</lpage><pub-id pub-id-type="pmcid">PMC5379957</pub-id><pub-id pub-id-type="pmid">28254829</pub-id><pub-id pub-id-type="doi">10.1083/jcb.201612067</pub-id></element-citation></ref><ref id="R12"><label>[12]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panov</surname><given-names>A</given-names></name><name><surname>Orynbayeva</surname><given-names>Z</given-names></name><name><surname>Vavilin</surname><given-names>V</given-names></name><name><surname>Lyakhovich</surname><given-names>V</given-names></name></person-group><article-title>Fatty acids in energy metabolism of the central nervous system</article-title><source>Biomed Res Int</source><year>2014</year><volume>2014</volume><pub-id pub-id-type="pmcid">PMC4026875</pub-id><pub-id pub-id-type="pmid">24883315</pub-id><pub-id pub-id-type="doi">10.1155/2014/472459</pub-id></element-citation></ref><ref id="R13"><label>[13]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Middleton</surname><given-names>B</given-names></name></person-group><article-title>The oxoacyl-coenzyme A thiolases of animal tissues</article-title><source>Biochem J</source><year>1973</year><volume>132</volume><issue>4</issue><fpage>717</fpage><lpage>730</lpage><pub-id pub-id-type="pmcid">PMC1177647</pub-id><pub-id pub-id-type="pmid">4721607</pub-id><pub-id pub-id-type="doi">10.1042/bj1320717</pub-id></element-citation></ref><ref id="R14"><label>[14]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ioannou</surname><given-names>MS</given-names></name><etal/></person-group><article-title>Neuron-Astrocyte Metabolic Coupling Protects against Activity-Induced Fatty Acid Toxicity</article-title><source>Cell</source><year>2019</year><volume>177</volume><issue>6</issue><fpage>1522</fpage><lpage>1535</lpage><elocation-id>e14</elocation-id><pub-id pub-id-type="pmid">31130380</pub-id></element-citation></ref><ref id="R15"><label>[15]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cardanho-Ramos</surname><given-names>C</given-names></name><etal/></person-group><article-title>Local mitochondrial replication in the periphery of neurons requires the eEF1A1 protein and thetranslation of nuclear-encoded proteins</article-title><source>iScience</source><year>2024</year><volume>27</volume><issue>4</issue><pub-id pub-id-type="pmcid">PMC10951640</pub-id><pub-id pub-id-type="pmid">38510136</pub-id><pub-id pub-id-type="doi">10.1016/j.isci.2024.109136</pub-id></element-citation></ref><ref id="R16"><label>[16]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Gharbawy</surname><given-names>A</given-names></name><name><surname>Vockley</surname><given-names>J</given-names></name></person-group><article-title>Defects of Fatty Acid Oxidation and the Carnitine Shuttle System</article-title><source>Pediatr Clin North Am</source><year>2018</year><volume>65</volume><issue>2</issue><fpage>317</fpage><lpage>335</lpage><pub-id pub-id-type="pmcid">PMC6566095</pub-id><pub-id pub-id-type="pmid">29502916</pub-id><pub-id pub-id-type="doi">10.1016/j.pcl.2017.11.006</pub-id></element-citation></ref><ref id="R17"><label>[17]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>Q</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>He</surname><given-names>H</given-names></name><name><surname>Yu</surname><given-names>P</given-names></name></person-group><article-title>Cellular Uptake, Metabolism and Sensing of Long-Chain Fatty Acids</article-title><source>Front Biosci - Landmark</source><year>2023</year><volume>28</volume><issue>1</issue><pub-id pub-id-type="pmid">36722264</pub-id></element-citation></ref><ref id="R18"><label>[18]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoppel</surname><given-names>C</given-names></name><name><surname>DiMarco</surname><given-names>JP</given-names></name><name><surname>Tandler</surname><given-names>B</given-names></name></person-group><article-title>Riboflavin and rat hepatic cell structure and function. Mitochondrial oxidative metabolism in deficiency states</article-title><source>J Biol Chem</source><year>1979</year><volume>254</volume><issue>10</issue><fpage>4164</fpage><lpage>4170</lpage><pub-id pub-id-type="pmid">571436</pub-id></element-citation></ref><ref id="R19"><label>[19]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grünig</surname><given-names>D</given-names></name><name><surname>Duthaler</surname><given-names>U</given-names></name><name><surname>Krähenbühl</surname><given-names>S</given-names></name></person-group><article-title>Effect of toxicants on fatty acid metabolism in HepG2 cells</article-title><source>Front Pharmacol</source><year>2018</year><volume>9</volume><month>APR</month><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="pmcid">PMC5924803</pub-id><pub-id pub-id-type="pmid">29740314</pub-id><pub-id pub-id-type="doi">10.3389/fphar.2018.00257</pub-id></element-citation></ref><ref id="R20"><label>[20]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tong</surname><given-names>D</given-names></name><etal/></person-group><article-title>NAD+ Repletion Reverses Heart Failure with Preserved Ejection Fraction</article-title><source>Circ Res</source><year>2021</year><volume>128</volume><issue>11</issue><fpage>1629</fpage><lpage>1641</lpage><pub-id pub-id-type="pmcid">PMC8159891</pub-id><pub-id pub-id-type="pmid">33882692</pub-id><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.120.317046</pub-id></element-citation></ref><ref id="R21"><label>[21]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Houten</surname><given-names>SM</given-names></name><name><surname>Wanders</surname><given-names>RJA</given-names></name></person-group><article-title>A general introduction to the biochemistry of mitochondrial fatty acid β-oxidation</article-title><source>J Inherit Metab Dis</source><year>2010</year><volume>33</volume><issue>5</issue><fpage>469</fpage><lpage>477</lpage><pub-id pub-id-type="pmcid">PMC2950079</pub-id><pub-id pub-id-type="pmid">20195903</pub-id><pub-id pub-id-type="doi">10.1007/s10545-010-9061-2</pub-id></element-citation></ref><ref id="R22"><label>[22]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ngo</surname><given-names>J</given-names></name><etal/></person-group><article-title>Mitochondrial morphology controls fatty acid utilization by changing CPT1 sensitivity to malonyl-CoA</article-title><source>EMBO J</source><year>2023</year><volume>42</volume><issue>11</issue><fpage>1</fpage><lpage>21</lpage><pub-id pub-id-type="pmcid">PMC10233380</pub-id><pub-id pub-id-type="pmid">36917141</pub-id><pub-id pub-id-type="doi">10.15252/embj.2022111901</pub-id></element-citation></ref><ref id="R23"><label>[23]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>M</given-names></name><etal/></person-group><article-title>DDHD2 is necessary for activity-driven fatty acid fueling of nerve terminal function</article-title><year>2023</year></element-citation></ref><ref id="R24"><label>[24]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>AM</given-names></name><name><surname>Blurton-jones</surname><given-names>M</given-names></name><name><surname>Rhee</surname><given-names>SW</given-names></name><name><surname>Cribbs</surname><given-names>DH</given-names></name><name><surname>Carl</surname><given-names>W</given-names></name></person-group><article-title>A microfluidic culture platform for CNS axonal injury, regeneration and transport</article-title><source>Nature</source><year>2005</year><fpage>599</fpage><lpage>605</lpage><pub-id pub-id-type="pmcid">PMC1558906</pub-id><pub-id pub-id-type="pmid">16094385</pub-id><pub-id pub-id-type="doi">10.1038/nmeth777</pub-id></element-citation></ref><ref id="R25"><label>[25]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rangaraju</surname><given-names>V</given-names></name><name><surname>Calloway</surname><given-names>N</given-names></name><name><surname>Ryan</surname><given-names>TA</given-names></name></person-group><article-title>Activity-Driven Local ATP Synthesis Is Required for Synaptic Function</article-title><source>Cell</source><year>2014</year><volume>156</volume><issue>4</issue><fpage>825</fpage><lpage>835</lpage><pub-id pub-id-type="pmcid">PMC3955179</pub-id><pub-id pub-id-type="pmid">24529383</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2013.12.042</pub-id></element-citation></ref><ref id="R26"><label>[26]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashrafi</surname><given-names>G</given-names></name><name><surname>de Juan-Sanz</surname><given-names>J</given-names></name><name><surname>Farrell</surname><given-names>RJ</given-names></name><name><surname>Ryan</surname><given-names>TA</given-names></name></person-group><article-title>Molecular Tuning of the Axonal Mitochondrial Ca2+ Uniporter Ensures Metabolic Flexibility of Neurotransmission</article-title><source>Neuron</source><year>2020</year><volume>105</volume><issue>4</issue><fpage>678</fpage><lpage>687</lpage><elocation-id>e5</elocation-id><pub-id pub-id-type="pmcid">PMC7035162</pub-id><pub-id pub-id-type="pmid">31862210</pub-id><pub-id pub-id-type="doi">10.1016/j.neuron.2019.11.020</pub-id></element-citation></ref><ref id="R27"><label>[27]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lundgaard</surname><given-names>I</given-names></name><etal/></person-group><article-title>Direct neuronal glucose uptake heralds activity-dependent increases in cerebral metabolism</article-title><source>Nat Commun</source><year>2015</year><volume>6</volume><pub-id pub-id-type="pmcid">PMC4410436</pub-id><pub-id pub-id-type="pmid">25904018</pub-id><pub-id pub-id-type="doi">10.1038/ncomms7807</pub-id></element-citation></ref><ref id="R28"><label>[28]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ebert</surname><given-names>D</given-names></name><name><surname>Haller</surname><given-names>RG</given-names></name><name><surname>Walton</surname><given-names>ME</given-names></name></person-group><article-title>Energy contribution of octanoate to intact rat brain metabolism measured by 13C nuclear magnetic resonance spectroscopy</article-title><source>J Neurosci</source><year>2003</year><volume>23</volume><issue>13</issue><fpage>5928</fpage><lpage>5935</lpage><pub-id pub-id-type="pmcid">PMC6741266</pub-id><pub-id pub-id-type="pmid">12843297</pub-id><pub-id pub-id-type="doi">10.1523/JNEUROSCI.23-13-05928.2003</pub-id></element-citation></ref><ref id="R29"><label>[29]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joachim</surname><given-names>JB</given-names></name><name><surname>Schulz</surname><given-names>G</given-names></name><name><surname>Laranjeira</surname><given-names>Antonio</given-names></name><name><surname>Van Huffel</surname><given-names>Leen</given-names></name><name><surname>Gartner</surname><given-names>Annette</given-names></name><name><surname>Vilain</surname><given-names>Sven</given-names></name><name><surname>Van Veldhoven</surname><given-names>Paul P</given-names></name><name><surname>Dotti</surname><given-names>Carlos G</given-names></name></person-group><article-title>Glial b-Oxidation regulates Drosophila Energy Metabolism</article-title><source>Sci Rep</source><year>2015</year><volume>5</volume><issue>7805</issue><pub-id pub-id-type="pmcid">PMC4295106</pub-id><pub-id pub-id-type="pmid">25588812</pub-id><pub-id pub-id-type="doi">10.1038/srep07805</pub-id></element-citation></ref><ref id="R30"><label>[30]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thevenet</surname><given-names>J</given-names></name><etal/></person-group><article-title>Medium-chain fatty acids inhibit mitochondrial metabolism in astrocytes promoting astrocyte-neuron lactate and ketone body shuttle systems</article-title><source>FASEB J</source><year>2016</year><volume>30</volume><issue>5</issue><fpage>1913</fpage><lpage>1926</lpage><pub-id pub-id-type="pmid">26839375</pub-id></element-citation></ref><ref id="R31"><label>[31]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schuurs-Hoeijmakers</surname><given-names>JHM</given-names></name><etal/></person-group><article-title>Mutations in DDHD2, encoding an intracellular phospholipase A1, cause a recessive form of complex hereditary spastic paraplegia</article-title><source>Am J Hum Genet</source><year>2012</year><volume>91</volume><issue>6</issue><fpage>1073</fpage><lpage>1081</lpage><pub-id pub-id-type="pmcid">PMC3516595</pub-id><pub-id pub-id-type="pmid">23176823</pub-id><pub-id pub-id-type="doi">10.1016/j.ajhg.2012.10.017</pub-id></element-citation></ref><ref id="R32"><label>[32]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inloes</surname><given-names>JM</given-names></name><etal/></person-group><article-title>The hereditary spastic paraplegia-related enzyme DDHD2 is a principal brain triglyceride lipase</article-title><source>Proc Natl Acad Sci U S A</source><year>2014</year><volume>111</volume><issue>41</issue><fpage>14924</fpage><lpage>14929</lpage><pub-id pub-id-type="pmcid">PMC4205627</pub-id><pub-id pub-id-type="pmid">25267624</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1413706111</pub-id></element-citation></ref><ref id="R33"><label>[33]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashrafi</surname><given-names>G</given-names></name><name><surname>Ryan</surname><given-names>TA</given-names></name></person-group><article-title>Glucose metabolism in nerve terminals</article-title><source>Curr Opin Neurobiol</source><year>2017</year><volume>45</volume><fpage>156</fpage><lpage>161</lpage><pub-id pub-id-type="pmcid">PMC5675126</pub-id><pub-id pub-id-type="pmid">28605677</pub-id><pub-id pub-id-type="doi">10.1016/j.conb.2017.03.007</pub-id></element-citation></ref><ref id="R34"><label>[34]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morant-Ferrando</surname><given-names>B</given-names></name><etal/></person-group><article-title>Fatty acid oxidation organizes mitochondrial supercomplexes to sustain astrocytic ROS and cognition</article-title><source>Nat Metab</source><year>2023</year><pub-id pub-id-type="pmcid">PMC10447235</pub-id><pub-id pub-id-type="pmid">37460843</pub-id><pub-id pub-id-type="doi">10.1038/s42255-023-00835-6</pub-id></element-citation></ref><ref id="R35"><label>[35]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dienel</surname><given-names>GA</given-names></name></person-group><article-title>Brain lactate metabolism: The discoveries and the controversies</article-title><source>J Cereb Blood Flow Metab</source><year>2012</year><volume>32</volume><issue>7</issue><fpage>1107</fpage><lpage>1138</lpage><pub-id pub-id-type="pmcid">PMC3390802</pub-id><pub-id pub-id-type="pmid">22186669</pub-id><pub-id pub-id-type="doi">10.1038/jcbfm.2011.175</pub-id></element-citation></ref><ref id="R36"><label>[36]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dienel</surname><given-names>GA</given-names></name><name><surname>Hertz</surname><given-names>L</given-names></name></person-group><article-title>Glucose and lactate metabolism during brain activation</article-title><source>J Neurosci Res</source><year>2001</year><volume>66</volume><issue>5</issue><fpage>824</fpage><lpage>838</lpage><pub-id pub-id-type="pmid">11746408</pub-id></element-citation></ref><ref id="R37"><label>[37]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romano</surname><given-names>A</given-names></name><etal/></person-group><article-title>Fats for thoughts: An update on brain fatty acid metabolism</article-title><source>Int J Biochem Cell Biol</source><year>2017</year><volume>84</volume><fpage>40</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">28065757</pub-id></element-citation></ref><ref id="R38"><label>[38]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tracey</surname><given-names>TJ</given-names></name><name><surname>Steyn</surname><given-names>FJ</given-names></name><name><surname>Wolvetang</surname><given-names>EJ</given-names></name><name><surname>Ngo</surname><given-names>ST</given-names></name></person-group><article-title>Neuronal lipid metabolism: Multiple pathways driving functional outcomes in health and disease</article-title><source>Front Mol Neurosci</source><year>2018</year><volume>11</volume><month>January</month><fpage>1</fpage><lpage>25</lpage><pub-id pub-id-type="pmcid">PMC5787076</pub-id><pub-id pub-id-type="pmid">29410613</pub-id><pub-id pub-id-type="doi">10.3389/fnmol.2018.00010</pub-id></element-citation></ref><ref id="R39"><label>[39]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adibhatla</surname><given-names>RM</given-names></name><name><surname>Hatcher</surname><given-names>JF</given-names></name></person-group><article-title>Altered lipid metabolism in brain injury and disorders</article-title><source>Subcell Biochem</source><year>2008</year><volume>49</volume><fpage>241</fpage><lpage>268</lpage><pub-id pub-id-type="pmcid">PMC2293298</pub-id><pub-id pub-id-type="pmid">18751914</pub-id><pub-id pub-id-type="doi">10.1007/978-1-4020-8831-5_9</pub-id></element-citation></ref><ref id="R40"><label>[40]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rangaraju</surname><given-names>V</given-names></name><name><surname>Lauterbach</surname><given-names>M</given-names></name><name><surname>Schuman</surname><given-names>EM</given-names></name></person-group><article-title>Spatially Stable Mitochondrial Compartments Fuel Local Translation during Plasticity</article-title><source>Cell</source><year>2019</year><volume>176</volume><issue>1–2</issue><fpage>73</fpage><lpage>84</lpage><elocation-id>e15</elocation-id><pub-id pub-id-type="pmid">30612742</pub-id></element-citation></ref><ref id="R41"><label>[41]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa-Pinto</surname><given-names>S</given-names></name><etal/></person-group><article-title>Communication defects with astroglia contribute to early impairments in the motor cortex plasticity of SOD1G93A mice</article-title><source>Neurobiol Dis</source><year>2024</year><volume>193</volume><comment>February</comment><pub-id pub-id-type="pmid">38336279</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Figure 1</label><caption><title>Synaptic mitochondria show higher efficiency towards FAO.</title><p>(<bold>A</bold>) Volcano plot showing the relative levels of identified proteins in synaptic (Syn) compared to non-synaptic (Non-Syn) mitochondria. The horizontal line defines the p-value statistical significance cutoff (p&lt;0.05). Proteins with differences below the p-value cut-off are depicted in grey. Proteins with increased expression in non-synaptic mitochondria are depicted in red. Proteins with increased expression in synaptic mitochondria are depicted in light blue. Protein involved in FAO are depicted in dark blue.</p><p>(<bold>B</bold>) Proteomic results of the relative levels comparing synaptic and non-synaptic mitochondria of FAO related proteins highlighted in (A). Data represented as Mean ± SD. n=3-4. Unpaired t-test. *p&lt;0.05; **p&lt;0.01; ***p&lt;0.001.</p><p>(<bold>C</bold>) Acyl-Coa dehydrogenase (ACAD) activity analysis assessed in isolated synaptic and non-synaptic mitochondria fractions, assessed in the presence of long- (LCFA), medium- (MCFA) and short-chain (SCFA) fatty acids (n=3 per group). Statistics: unpaired Student’s t-test; *p&lt;0,05.</p><p>(<bold>D</bold>) Quantification via immunoblotting of the expression of LCAD.</p><p>(<bold>E</bold>) Representative immunoblot images comparing synaptic and non-synaptic mitochondria for LCAD expression depicted in (D). VDAC1 was used as a loading control. Results are presented as fold-change to non-synaptic mitochondria (N=4). Statistics: unpaired Student’s t-test; **p&lt;0,01.</p><p>(<bold>F</bold>) Short-chain 3-hydroxyacyl-CoA dehydrogenase (SCHAD) activity analysis assessed in isolated synaptic and non-synaptic mitochondria fractions (n=9). Statistics: unpaired Student’s t-test; *p&lt;0,05.</p><p>(<bold>G</bold>) Metabolism of long- (LCFA), medium- (MCFA) and short-chain (SCFA) fatty acids assessed using Mito Plates S-1™. Results were normalized to wells containing the vehicle control of fatty acids. (N=4). Statistics: unpaired Student’s t-test; *p&lt;0,05.</p><p>(<bold>H</bold>) CPT1 activity in the presence of 40µM malonyl-CoA (M-CoA) measured in isolated non-synaptic and synaptic mitochondria. Results were normalized to the activity of each fraction without the presence of M-CoA and presented as fold-change. (N=3). Statistics: unpaired Student’s t-test; *p&lt;0,05.</p><p>(<bold>I</bold>) Fatty acid uptake capacity measured in isolated non-synaptic and synaptic mitochondria. (N=3). Statistics: unpaired Student’s t-test; **p&lt;0,01</p></caption><graphic xlink:href="EMS205911-f001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><title>Fatty acid fuelling benefits respiratory flexibility of brain mitochondria.</title><p>(<bold>A</bold>) Representative graphs of a Seahorse XF Cell Mito Stress Test Kit adapted for isolated mitochondria, performed in a Seahorse XFe24 Analyzer setup in isolated non-synaptic and synaptic isolated mitochondria fractions fuelled with long- (LCFA), medium- (MCFA) and short-chain (SCFA) fatty acids (n=3 per group).</p><p>(<bold>B</bold>) Respiratory parameters assessed on non-synaptic and synaptic isolated mitochondria fractions in the presence of long-chain fatty acids (LCFA). Results are presented as fold change to the vehicle control of fatty acids (n=3). Statistics: unpaired Student’s t-test; *p&lt;0,05.</p><p>(<bold>C</bold>) Respiratory parameters assessed on non-synaptic and synaptic isolated mitochondria fractions in the presence of medium-chain fatty acids (MCFA). Results are presented as fold change to the vehicle control of fatty acids (n=3). Statistics: unpaired Student’s t-test; *p&lt;0,05 ; ***p&lt;0,001.</p><p>(<bold>D</bold>) Respiratory parameters assessed on non-synaptic and synaptic isolated mitochondria fractions in the presence of short-chain fatty acids (SCFA). Results are presented as fold change to the vehicle control of fatty acids (n=3). Statistics: unpaired Student’s t-test; *p&lt;0,05; **p&lt;0,01.</p></caption><graphic xlink:href="EMS205911-f002"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><title>Neuronal respiration benefits from FAO.</title><p>(<bold>A</bold>) Representative graphs of a Seahorse XF Cell Mito Stress Test Kit, performed in a Seahorse XFe24 Analyzer setup in primary neurons (DIV10) fueled with long-chain fatty acids (LCFA) in the form of Palmitate (n=3-6 per group).</p><p>(<bold>B</bold>) Analysis of respiratory parameters of primary neurons fueled with Palmitate. Results are presented as fold change to the vehicle control of fatty acids (BSA). (n=3-6 per group). Statistics: ordinary one-way ANOVA with Dunnet’s multiple comparisons test; *p&lt;0,05.</p><p>(<bold>C</bold>) Representative graphs of a Seahorse XF Cell Mito Stress Test Kit, performed in a Seahorse XFe24 Analyzer setup in primary neurons (DIV10) fueled with medium-chain fatty acids (MCFA) in the form of Octanoate (n=4 per group).</p><p>(<bold>D</bold>) Analysis of respiratory parameters of primary neurons fueled with Octanoate. Results are presented as fold change to the vehicle control of fatty acids (BSA). (n=4 per group). Statistics: unpaired Student’s t-test; *p&lt;0,05; **p&lt;0,01.</p></caption><graphic xlink:href="EMS205911-f003"/></fig><fig id="F4" position="float"><label>Figure 4</label><caption><title>Fatty acid fueling significantly contributes to neuronal ATP levels.</title><p>(<bold>A</bold>) Analysis of the effect of Palmitate and Etomoxir and (<bold>B</bold>) Octanoate on the ATP content of primary neurons (DIV10). Results are presented as fold change to the vehicle control of fatty acids (BSA). (n=4 per group). Statistics: (Palmitate and Etomoxir) ordinary one-way ANOVA with Dunnet’s multiple comparisons test; *p&lt;0,05; (Octanoate) unpaired Student’s t-test; ***p&lt;0,001 for Octanoate.</p></caption><graphic xlink:href="EMS205911-f004"/></fig><fig id="F5" position="float"><label>Figure 5</label><caption><title>Fatty acid uptake occurs at neuronal periphery in the presence of glucose</title><p>Confocal images show uptake of Red-C12 incubated for 24h exclusively in the axonal compartment of mouse primary neurons (DIV10) cultured in microfluidic devices. Fatty acid uptake was observed at the (<bold>A</bold>) cellular (via co-staining with neuronal marker anti-Tubulin β3 antibody) and (<bold>B</bold>) mitochondrial (via co-staining with mitochondrial marker anti-HSP60 antibody) levels, evidence showing that metabolization of this fuel can occur locally at the periphery of neurons.</p></caption><graphic xlink:href="EMS205911-f005"/></fig><fig id="F6" position="float"><label>Figure 6</label><caption><title>Long-chain FAO increases synaptic potentiation.</title><p>(<bold>A</bold>) Representative traces of spontaneous postsynaptic currents in primary neurons (DIV19-21) incubated with long-chain fatty acids (LCFA), alone or in combination with the inhibitor Etomoxir, as well as vehicle control BSA.</p><p>Graphical analysis of whole-cell patch-clamp recording depicting frequency <bold>(B)</bold> and amplitude <bold>(C)</bold> of spontaneous postsynaptic currents performed in primary neurons (DIV19-21) fueled with long-chain fatty acids (LCFA) in the form of Palmitate. Etomoxir was incubated prior to palmitate to assess specificity of palmitate Effect. Recording conducted in Axopatch 200B (Axon Instruments) amplifier. Results are presented as fold-change to BSA (N=3). Statistics: ordinary one-way ANOVA with Dunnet’s multiple comparisons test; **p&lt;0,01</p><p><bold>(D)</bold> Representative immunoblot images comparing primary neurons (DIV19-21) fueled with palmitate or BSA for the expression of GluA1, MDAR2A and NMDAR2B. B-actin was used as a loading control. Statistics: unpaired Student’s t-test. (E) Quantification via immunoblotting of the expression of GluA1, NMDAR2A and NMDAR2B. Results are presented as fold-change to BSA (N=3).</p></caption><graphic xlink:href="EMS205911-f006"/></fig></floats-group></article>